Posts by: Daniela Semedo, PhD

Daniela Semedo, PhD

Daniela holds a PhD in Clinical Psychology from The University of Edinburgh, United Kingdom, a MSc in Health Psychology and a BSc in Clinical Psychology. Her work has been focused on vulnerability to psychopathology and early identification and intervention in psychosis.

February 3, 2017February 3, 2017

CHMP Favors Xeljanz Be Approved to Treat Patients with Active Rheumatoid Arthritis in EU

News

The Committee for Medicinal Products for Human Use (CHMP) is recommending the approval of Pfizer’s Xeljanz (tofacitinib citrate, 5 mg tablets twice daily) as a treatment for adults with moderate-to-severely active rheumatoid arthritis (RA) in ... Read more

February 1, 2017February 1, 2017

EU Closer to Approving ABP 501 as Alternative to Humira for Rheumatoid Arthritis

News, rheumatoid arthritis

Amgen has taken a key step toward obtaining European Union approval of its ABP 501 biosimilar therapy for rheumatoid arthritis (RA) and other conditions. The European Medicines Agency’s Committee for Medicinal Products for Human ... Read more

January 25, 2017January 25, 2017

ACR Writes Congressional Leaders About Healthcare Priorities for Rheumatic Diseases

News

As the 115th U.S. Congress considers potential healthcare reform, the American College of Rheumatology (ACR) sent a letter to congressional leaders to ensure that proposals will protect and promote access ... Read more

January 23, 2017January 23, 2017

Targeting SCIMP Protein Shows Potential in Inflammatory Diseases Like RA

News

The ability to reduce or “switch off” inflammation may be possible thanks to a new discovery made by researchers at the University of Queensland (UQ) in Australia. They found that a ... Read more

January 16, 2017January 16, 2017

Crafoord Prize Honors 3 for Discoveries in Regulatory T-cells That Control Immune Responses

News

This year’s Crafoord Prize in Polyarthritis was awarded to three researchers in the field of immunology for discoveries made in immune regulatory T-cells, a subpopulation of T-cells that modulate the immune system, maintain tolerance to ... Read more

January 9, 2017January 9, 2017

Pfizer’s Alternative to Humira Proves Effective in Rheumatoid-arthritis Trial

News

A therapy that Pfizer developed as a cheaper alternative to Humira (adalimumab) has shown it is as effective as Humira in treating rheumatoid arthritis. The results came in a Phase 3 trial of PF-06410293, ... Read more

December 14, 2016December 14, 2016

Less Than Half of Opiates Used by RA Patients Were Prescribed by Rheumatologist

News

New research indicates 43 percent of patients with rheumatoid arthritis (RA) who were prescribed opiates between 2006 and 2014 had their prescriptions written by a rheumatology specialist. These were the findings ... Read more

December 7, 2016December 7, 2016

Report Highlights Deficiencies in Treatment of Arthritis Patients in Wales

News, rheumatoid arthritis

The British Society for Rheumatology (BSR) and the National Rheumatoid Arthritis Society (NRAS) have jointly issued the report, “Rheumatology in Wales: The State of Play,” exploring rheumatology services in Wales ... Read more

November 30, 2016November 30, 2016

Children Born to Moms with Rheumatoid Arthritis at Risk for Epilepsy, Study Finds

News, rheumatoid arthritis

Children born to mothers with rheumatoid arthritis (RA) are at increased risk for developing epilepsy, new research shows. The study, “Parental rheumatoid arthritis and childhood epilepsy,” published in the journal ... Read more

November 9, 2016November 9, 2016

Obesity Causes Rheumatoid Arthritis to Develop Earlier, Delays Treatment Effect in Mice

News

New research in mice shows that obesity causes rheumatoid arthritis (RA) to develop earlier, and may play a role in slowing the effect of anti-TNF-alpha antibody drugs, the current standard medication ... Read more